Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Lithium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Lithium Ion SCHEMBL7905865 | 0.94 | — | — | |
| SCHEMBL8591012 | 0.93 | FNTA (0.61) | — | |
| Lithium Ion SCHEMBL7910120 | 0.93 | FNTA (0.60) | — | |
| SCHEMBL7904831 | 0.92 | FNTA (0.60) | — | |
| SCHEMBL7904838 | 0.92 | FNTA (0.60) | — | |
| Lithium Ion SCHEMBL7903781 | 0.90 | — | — | |
| Lithium Ion SCHEMBL7906918 | 0.89 | FNTA (0.56) | — | |
| Lithium Ion SCHEMBL7905067 | 0.88 | FNTA (0.57) | — | |
| SCHEMBL8587153 | 0.87 | FNTA (0.63) | — | |
| Lithium Ion SCHEMBL7897803 | 0.87 | FNTA (0.54) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6204293-B1 | INHIBITING POST-TRANSLATIONAL MODIFICATION OF THE ONCOGENIC RAS PROTEIN BY PROTEIN FARNESYLTRANSFERASE, PROTEIN GERANYLGERANYLTRANSFERASE, OR BOTH | UNIVERSITY OF PITTSBURGH | 2001-03-20 | — | — | US | disclosed |